AU2001284324A1 - Controlled release formulation of erythromycin or a derivative thereof - Google Patents
Controlled release formulation of erythromycin or a derivative thereofInfo
- Publication number
- AU2001284324A1 AU2001284324A1 AU2001284324A AU8432401A AU2001284324A1 AU 2001284324 A1 AU2001284324 A1 AU 2001284324A1 AU 2001284324 A AU2001284324 A AU 2001284324A AU 8432401 A AU8432401 A AU 8432401A AU 2001284324 A1 AU2001284324 A1 AU 2001284324A1
- Authority
- AU
- Australia
- Prior art keywords
- erythromycin
- derivative
- controlled release
- release formulation
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN778DE2000 IN192748B (en) | 2000-08-29 | 2000-08-29 | |
IN778/DEL/2000 | 2000-08-29 | ||
PCT/IB2001/001564 WO2002017885A2 (en) | 2000-08-29 | 2001-08-29 | Controlled release formulation of erythromycin or a derivative thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001284324A1 true AU2001284324A1 (en) | 2002-03-13 |
Family
ID=11097084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001284324A Abandoned AU2001284324A1 (en) | 2000-08-29 | 2001-08-29 | Controlled release formulation of erythromycin or a derivative thereof |
Country Status (5)
Country | Link |
---|---|
US (1) | US20020081332A1 (en) |
EP (1) | EP1315478A2 (en) |
AU (1) | AU2001284324A1 (en) |
IN (1) | IN192748B (en) |
WO (1) | WO2002017885A2 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
WO2001064224A1 (en) * | 2000-02-29 | 2001-09-07 | Teva Pharmaceutical Industries Ltd. | Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same |
AU2001263812B2 (en) * | 2000-03-28 | 2004-09-23 | Sandoz Ag | Granulated particles with masked taste |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
WO2003017981A1 (en) * | 2001-08-29 | 2003-03-06 | Ranbaxy Laboratories Limited | Controlled release formulation of clarithromycin or tinidazol |
RU2004119035A (en) * | 2001-11-21 | 2005-11-20 | Э-З-Эм, Инк. (Us) | COMPOSITIONS INTENDED FOR USE IN MEDICAL AND DIAGNOSTIC PROCEDURES |
US20070167380A1 (en) * | 2002-04-03 | 2007-07-19 | Rahul Dabre | Taste masked compositions of erythromycin a and derivatives thereof |
CN1652753A (en) * | 2002-04-03 | 2005-08-10 | 兰贝克赛实验室有限公司 | Clarithromycin formulations having improved bioavailability |
US7063862B2 (en) * | 2003-06-03 | 2006-06-20 | Biokey, Inc. | Pharmaceutical composition and method for treating |
WO2005004919A2 (en) * | 2003-07-02 | 2005-01-20 | Eurand, Inc. | Extended release systems for macrolide antibiotics |
CA2533165A1 (en) * | 2003-07-21 | 2005-01-27 | Bio-Dar Ltd. | Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention |
US8313776B2 (en) | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
JP2006528190A (en) | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | Antibiotic preparations, their use and preparation |
WO2005009364A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
US8758820B2 (en) | 2003-08-11 | 2014-06-24 | Shionogi Inc. | Robust pellet |
US8062672B2 (en) | 2003-08-12 | 2011-11-22 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
CA2535780A1 (en) | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
CA2538064C (en) | 2003-09-15 | 2013-12-17 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
US8168228B2 (en) | 2003-10-17 | 2012-05-01 | Sandoz Ag | Antibiotic clarithromycin micropellet compositions |
US7943585B2 (en) | 2003-12-22 | 2011-05-17 | Sandoz, Inc. | Extended release antibiotic composition |
US20050260263A1 (en) * | 2004-05-18 | 2005-11-24 | Panion & Bf Biotech Inc. | Sustained release formulation for sparingly soluble main drugs |
CA2572292A1 (en) | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
WO2011125075A2 (en) * | 2010-04-08 | 2011-10-13 | Fdc Limited | A novel gastroretentive delivery of macrolide |
EP2671571A1 (en) * | 2012-06-05 | 2013-12-11 | Sanovel Ilac Sanayi ve Ticaret A.S. | Controlled-release formulations of clarithromycin |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4076804A (en) * | 1975-07-18 | 1978-02-28 | Abbott Laboratories | Erythromycin therapy |
GB1577196A (en) * | 1977-06-03 | 1980-10-22 | Ile De France | Compositions containing erythromycin and metoclopramide |
US5009897A (en) * | 1988-06-24 | 1991-04-23 | Abbott Laboratories | Pharmaceutical granules and tablets made therefrom |
US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
US6010718A (en) * | 1997-04-11 | 2000-01-04 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
CA2343760A1 (en) * | 1998-09-14 | 2000-03-23 | Ranbaxy Laboratories Limited | Orally administered controlled drug delivery system providing temporal and spatial control |
SI20150A (en) * | 1999-02-19 | 2000-08-31 | Lek, Tovarna Farmacevtskih In | Directly compressible matrix for controlled release of the daily dose of clarytomicyne |
-
2000
- 2000-08-29 IN IN778DE2000 patent/IN192748B/en unknown
-
2001
- 2001-08-29 AU AU2001284324A patent/AU2001284324A1/en not_active Abandoned
- 2001-08-29 US US09/941,970 patent/US20020081332A1/en not_active Abandoned
- 2001-08-29 EP EP01963298A patent/EP1315478A2/en not_active Withdrawn
- 2001-08-29 WO PCT/IB2001/001564 patent/WO2002017885A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002017885A2 (en) | 2002-03-07 |
WO2002017885A3 (en) | 2002-09-06 |
US20020081332A1 (en) | 2002-06-27 |
EP1315478A2 (en) | 2003-06-04 |
IN192748B (en) | 2004-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001284324A1 (en) | Controlled release formulation of erythromycin or a derivative thereof | |
AU2002229140A1 (en) | Controlled release pharmaceutical composition | |
AU2001286677A1 (en) | Controlled release of substances | |
AU2002215218A1 (en) | Isoxazole derivatives | |
AU2002248377A1 (en) | A controlled release pharmaceutical composition | |
HUP0203540A3 (en) | Extended release formulations of erythromycin derivatives | |
IL240001A0 (en) | Controlled release hydrocodone formulations | |
AU2001290825A1 (en) | Controlled release formulations and methods for their production and use | |
AU2001264256A1 (en) | Plaster | |
AU2001269529A1 (en) | Medicine comprising dicyanopyridine derivative | |
AU2001230584A1 (en) | 1h-imidazopyridine derivatives | |
AU2001252679A1 (en) | Plaster | |
AU2001230537A1 (en) | Pyridoxazine derivatives | |
AU2001278790A1 (en) | 1h-imidazopyridine derivatives | |
AU2001287977A1 (en) | Controlled release formulations for oral administration | |
AU2001252247A1 (en) | Isothiazole derivatives | |
AU4213299A (en) | Controlled release of substances | |
AU2001232948A1 (en) | Controlled release of drugs | |
AU5256301A (en) | Froindazole derivative | |
AU2001246861A1 (en) | Sustained release preparations | |
AU2001248772A1 (en) | Sustained release drug compositions | |
AU2002220578A1 (en) | O-substituted 6-methyl-tramadol derivatives | |
AU5246901A (en) | A coating composition for facilitating controlled release | |
AU2001230565A1 (en) | Perfluoroisopropylbenzene derivatives | |
AU2001254661A1 (en) | Aminosulfonylbiphenyl derivatives |